Abstract
The likelihood of amyloid deposition in the cerebral vasculature (cerebral amyloid angiopathy; CAA) increases with age1-3. Particularly in Alzheimer’s disease (AD), CAA can be detected in up to 90% of the patients4-6. CAA of the ß-amyloid-type (Aß-CAA) affects primarily leptomeningeal and cortical vessels and is associated with degeneration of smooth muscle cells and endothelial cells, as well as blood-brain barrier damage. Severe Aß-CAA can cause fatal cerebral hemorrhage and increases the risk of cerebral microinfarcts7-9. Genetic variations that are causative or risk factors for Aß-CAA have been identified, such as mutations in the genes for ß-amyloid precursor protein (APP), presenilins 1 and 2, and possibly cystatin C, as well as polymorphisms in apolipoprotein E3. In normal aging and AD, Aß-CAA is associated with parenchymal Aß plaques. However, Aß-CAA can also occur in the absence of plaques, as evidenced in hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D)10-12.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tomonaga M (1981) Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 29: 151–157.
Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14: 924–928.
Walker LC, Durham RA (1999) Cerebrovascular amyloidosis: experimental analysis in vitro and in vivo. Histol Histopathol 14: 827–837.
Esiri MM, Wilcock GK (1986) Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 49: 1221–1226.
Yamada M, Tsukagoshi H, Otomo E et al. (1987) Cerebral amyloid angiopathy in the aged. J Neurol 234: 371–376.
Yamada M (2000) Cerebral amyloid angiopathy: an overview. Neuropathology 20: 822.
Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18: 311–324.
Itoh Y, Yamada M, Hayakawa M et al. (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116: 135–141.
Vonsattel JP, Myers RH, Hedley-Whyte ET et al. (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30: 637–649.
Wattendorff AR, Bots GT, Went LN et al. (1982) Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J Neurol Sci 55: 121–135.
Haan J, Hardy JA, Roos RA (1991) Hereditary cerebral hemorrhage with amyloidosis-Dutch type: its importance for Alzheimer research. Trends Neurosci 14: 231–234.
Levy E, Carman MD, Fernandez-Madrid et al. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124–1126.
Walker LC (1997) Animal models of cerebral beta-amyloid angiopathy. Brain Res Rev 25: 70–84.
Wisniewski HM, Frackowiak J, Mazur-Kolecka B (1995) In vitro production of betaamyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 183: 120–123.
Wei LH, Walker LC, Levy E (1996) Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. Stroke 27: 2080–2085.
Games D, Adams D, Alessandrini R, et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523–527.
Hsiao K, Chapman P, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99–102.
Holtzman DM, Fagan AM, Mackey B et al. (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model. Ann Neurol 47: 739–747.
Sturchler-Pierrat C, Abramowski D, Duke M et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287–13292.
Calhoun ME, Burgermeister P, Phinney AL et al. (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96: 14088–14093.
Winkler DT, Bondolfi L, Herzig MC et al. (2000) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. (submitted)
Van Dorpe J, Smeijers L, Dewachter I et al. (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol (in press)
Mandybur TI (1975) The incidence of cerebral amyloid angiopathy in Alzheimer’s disease. Neurology 25: 120–126.
Ellis RJ, Olichney JM, Thal LJ et al. (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46: 1592–1596.
Wyss-Coray T, Masliah E, Mallory M et al. (1997) Amyloidogenic role of cytokine TGF-betal in transgenic mice and in Alzheimer’s disease. Nature 389: 603–606.
Hendriks L, van Duijn CM, Cras P et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1: 218–221.
Cras P, van Harskamp F, Hendriks L et al. (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->GIy mutation. Acta Neuropathol 96: 253–260.
Kumar-Singh S, Ceuterick C, Lubke U et al. (2000) Pathology of Flemish APP692 Alzheimer’s disease suggests that core containing plaques are angiocentric. Neurobiol Aging 21: S66.
Kumar-Singh S, Dewachter I, Moechars D et al. (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7: 9–22.
Levy E, Lopez-Otin C, Ghiso J et al. (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169: 1771–1778.
Vidal R, Frangione B, Rostagno A et al. (1999) A stop-codon mutation in theBRIgene associated with familial British dementia. Nature 399: 776–781.
Vidal R, Revesz T, Rostagno A et al. (2000) A decamer duplication in the 3’ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97: 4920–4925.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herzig, M.C., Winkler, D.T., Walker, L.C., Jucker, M. (2001). Transgenic Mouse Models of Cerebral Amyloid Angiopathy. In: Tolnay, M., Probst, A. (eds) Neuropathology and Genetics of Dementia. Advances in Experimental Medicine and Biology, vol 487. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1249-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1249-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5461-1
Online ISBN: 978-1-4615-1249-3
eBook Packages: Springer Book Archive